Which one of the following agents has been associated with hemorrhagic stroke?
**Core Concept**
The question is testing the association between a specific medication and a rare but serious side effect, hemorrhagic stroke. Hemorrhagic stroke occurs when there is bleeding in the brain, which can be caused by various factors including the use of certain medications.
**Why the Correct Answer is Right**
The correct answer is associated with a mechanism that involves the inhibition of an enzyme responsible for the breakdown of a neurotransmitter, leading to an accumulation of this neurotransmitter and subsequent vasodilation. This can increase the risk of hemorrhagic stroke, especially in patients with a history of hypertension or other underlying conditions.
**Why Each Wrong Option is Incorrect**
* **Option A:** This medication is not typically associated with hemorrhagic stroke and is more commonly linked to other side effects such as gastrointestinal disturbances.
* **Option B:** This medication is not known to cause hemorrhagic stroke and is primarily used to treat a different condition.
* **Option C:** This medication is not associated with an increased risk of hemorrhagic stroke and is actually used to prevent this very condition in certain patients.
**Clinical Pearl / High-Yield Fact**
Be aware that certain medications, especially those that affect neurotransmitter metabolism, can increase the risk of hemorrhagic stroke in susceptible individuals.
**Correct Answer: C. Sumatriptan**